[1] 国家自然科学基金面上项目，EML4-ALK融合蛋白在肺癌相关静脉血栓栓塞症发病中的作用及其机制，48万，主持，2023-08-20--2027-12-31

[2]院级临床研究孵化项目，免疫检查点抑制剂治疗肺癌患者血栓发生风险预测模型构建及应用研究，50万元，主持，2022-08-09--2027-07-30

[3]北京市呼吸疾病研究所改革与发展项目（自主创新），CT定义肺气肿对接受不同抗肿瘤治疗的肺癌患者预后影响及机制研究，主持，2025/01-2027/12

1、重要学术论文

[1]Zhang Y, Hu Y, Zhang S, Zhu M, Lu J, Hu B, Guo X, Zhang Y. Effects of pre-operative biopsy on recurrence and survival in stage I lung adenocarcinoma patients in China. ERJ Open Res. 2023 Aug 14;9(4):00675-2022. doi: 10.1183/23120541.00675-2022IF: 4.6 Q2 B4. PMID: 37583968IF: 4.6 Q2 B4; PMCID: PMC10423981IF: 4.6 Q2 B4.

[2]Zhang Y, Yi J, Su Y, et al. The association of chest CT-defined visual emphysema and prognosis in patients with non-small cell lung cancer. ERJ Open Res 2023.doi.org/10.1183/23120541.00195-2023IF: 4.6 Q2 B4.

[3]Feifei Dou, Yuan Zhang, Jiawen Yi, Min Zhu, Shu Zhang, Di Zhang, Yuhui Zhang*. Association of ALK rearrangement and risk of venous thromboembolism in patients with non-small cell lung cancer: A prospective cohort study. Thrombosis Research, 2020 , 186(2)：36-41.

[4] Jie Li#, Jiawen Yi# , Lin Hua , Yanping Su , Meirong Huo , Feifei Dou , Zhenguo Zhai , Min Zhu , Shu Zhang , Yuhui Zhang*.  Development and validation of a predictive score for venous thromboembolism in newly diagnosed non-small cell lung cancer Thrombosis Research, 2021 , 208(10)：45-51.

[5]Jiawen Yi #, Huang Chen#, Jie Li, Xingran Jiang, Yan Xu, Mengzhao Wang, Zheng Wang, Zhenguo Zhai, Yanhong Ren*, Yuhui Zhang*. The association between ROS1 rearrangement and risk of thromboembolic events in patients with advanced non-small cell lung cancer: a multicenter study in China. Thromb J 2022: 20(1): 56-65.

[6]Yuan Zhang#, Yanjun Zhang#, Yi Hu#, Shu Zhang, Min Zhu, Bin Hu, Xiaojuan Guo, Jun Lu*, Yuhui Zhang*. Validation of the novel International Association for the Study of Lung Cancer grading system and prognostic value of filigree micropapillary and discohesive growth pattern in invasive pulmonary adenocarcinoma. Lung Cancer 2022: 175: 79-87.

[7] Zhuo Ma, Ximu Sun, Yi Zhang, Hao Li, Dan Sun, Zhuoling An*, Yuhui Zhang*. Risk of Thromboembolic Events in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Meta-analysis of Randomized Controlled Trials. Thromb Haemost 2022: 122(10): 1757-1766.

[8]Chunguo Jiang#, Min Zhu#, Dan Wei, Hongyan Duan, Yuhui Zhang*, Xiaokai Feng*.SCLC and anti-GABABR encephalitis: A retrospective analysis of 60 cases in China.Thoracic Cancer.2022.13(6).804-810.

[9]Shu Zhang # , Yuan Zhang # , Wei Feng, Zhongyue Shi, Huanzhong Shi, Yuhui Zhang*.Prediction modeling using routine clinical parameters to stratify survival in malignant pleural mesothelioma patients complicated with malignant pleural effusion..Thoracic Cancer.2021.12(24).3304-3309.

[10]Yanping Su, Meirong Huo, Lin Hua, Yuan Zhang, Jiawen Yi, Shu Zhang, Jie Li , Yuhui Zhang*.Association of Venous Thromboembolism and Early Mortality in Patients with Newly Diagnosed Metastatic Non-Small Cell Lung Cancer.Cancer Management and Research.2021.2021（13）.4031-4040

[11]Duo Chen, Luyu Huang, Haiyu Zhou*, Yuhui Zhang*.Combining IL-10 and Oncolytic Adenovirus Demonstrates Enhanced Antitumor Efficacy Through CD8+ T Cells.Frontiers in Immunology.2021.12.615089.

[12]Dong Leng, Xiaoxi Huang, Jiawen Yi, Hongying Zhao,and Yuhui Zhang* .HYAL1 Is Downregulated in Idiopathic Pulmonary Fibrosis and Inhibits HFL-1 Fibroblast Proliferation When Upregulated.BioMed Research International .2020. https://doi.org/10.1155/2020/3659451IF: NA NA NA

[13]Aili Wang#, Xin Zhang#, Jiawen Yi, Min Zhu & Yuhui Zhang*.Successful treatment of advanced lung adenocarcinoma complicated with Lambert-Eaton myasthenic syndrome: A case report and literature review .Thoracic Cancer .2020.11(5).1334-1338.

[14]Feifei Doua, Yuan Zhang, Jiawen Yi, Min Zhu, Shu Zhang, Di Zhang, Yuhui Zhang* .Association of ALK rearrangement and risk of venous thromboembolism in patients with non-small cell lung cancer: A prospective cohort study.Thrombosis Research.2020.186(2).36-41

[15]Meiru Wang, Xiaoxi Huang, Min Zhu, Shu Zhang, Yuhui Zhang*.High concentration of the plasma microparticles for venous thromboembolism associated with lung cancer .Clinical Respiratory Journal.2020.

[16] ZhangY, Lang L#, Guo X, Huang K, Yi J, Yuan Y, ZhuM, Zhang S, Hu B, Li X, ZhangY*. The association and impact ofradiographic, pathological emphysema and spirometric airway obstruction onpatients with resectable lung adenocarcinoma. Respir Res. 2025 Apr16;26(1):151. (JCR Q1, IF 5.0)  

[17]ZhangY, Zhao J, Ma Z, Yi J, Yuan Y, Lang L, ZhangC, Zhu M, ZhangY*. Immune checkpoint inhibitors foradvanced non-small cell lung cancer with preexisting COPD and CT-definedemphysema: A systematic review and meta-analysis. Lung Cancer. 2025 Aug4;207:108700. (JCR Q1, IF 4.4) 

[18]ZhangXL#, Zhang C#, Lang L, Yi JW, Zhu M*, ZhangYH*. Association of Baseline SerumUric Acid With Venous Thromboembolism and Clinical Outcomes in Patients WithNon-Small Cell Lung Cancer. Thorac Cancer. 2025 May;16(9):e70076.(JCR Q2, IF 2.3)  

[19]Ma Z, Zhang Y, Sun D#, Zhu M, Yi J, Zhang Y, An Z*, ZhangY*.Thromboembolic and bleeding events associated with angiogenesis inhibitors incancer patients. Expert Opin Drug Saf. 2025 May 21:1-10. （JCR Q2, IF 3.1)

2、主编或副主编的著作/译著

3、重要奖项